Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Emerging Infectious Diseases
|
April 13, 2023
US National Institutes of Health Prioritization of SARS-CoV-2 Variants
Sam Turner, Arghavan Alisoltani, Debbie Bratt, et al.
Cell Host & Microbe
|
August 16, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A Bricault, Karina Yusim, Michael S Seaman, et al.
Cell Host & Microbe
|
January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A Bricault, Karina Yusim, Michael S Seaman, et al.
Cell
|
August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Nature
|
April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Emerging Infectious Diseases
|
April 13, 2023
US National Institutes of Health Prioritization of SARS-CoV-2 Variants
Sam Turner, Arghavan Alisoltani, Debbie Bratt, et al.
Cell Host & Microbe
|
August 16, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A Bricault, Karina Yusim, Michael S Seaman, et al.
Cell Host & Microbe
|
January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A Bricault, Karina Yusim, Michael S Seaman, et al.
Cell
|
August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Nature
|
April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Page
of 5